KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,187,008 | -22.0% | 18,848 | 0.0% | 0.01% | -21.4% |
| Q2 2023 | $4,087,189 | +31.1% | 18,848 | +9.8% | 0.01% | +27.3% |
| Q1 2023 | $3,118,577 | -7.6% | 17,169 | 0.0% | 0.01% | -15.4% |
| Q4 2022 | $3,373,709 | -12.6% | 17,169 | 0.0% | 0.01% | -18.8% |
| Q3 2022 | $3,862,000 | +40.5% | 17,169 | -21.0% | 0.02% | +60.0% |
| Q2 2022 | $2,749,000 | -7.3% | 21,733 | -7.1% | 0.01% | +11.1% |
| Q1 2022 | $2,965,000 | +6.7% | 23,389 | +10.3% | 0.01% | +12.5% |
| Q4 2021 | $2,779,000 | -12.7% | 21,210 | -18.5% | 0.01% | -20.0% |
| Q3 2021 | $3,183,000 | +27.4% | 26,016 | +18.7% | 0.01% | +25.0% |
| Q2 2021 | $2,498,000 | – | 21,917 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 908,708 | $109,254,000 | 35.05% |
| Sofinnova Investments, Inc. | 1,952,441 | $234,742,000 | 14.11% |
| Logos Global Management LP | 200,000 | $24,046,000 | 2.35% |
| First Light Asset Management, LLC | 258,500 | $31,079,000 | 2.06% |
| Eventide Asset Management | 971,077 | $116,753,000 | 1.73% |
| DAFNA Capital Management LLC | 48,000 | $5,771,000 | 1.37% |
| CATALYST PRIVATE WEALTH, LLC | 13,006 | $1,564,000 | 1.10% |
| Rock Springs Capital Management LP | 368,764 | $44,336,000 | 0.97% |
| Pinz Capital Management, LP | 28,805 | $3,463,000 | 0.92% |
| MILLER VALUE PARTNERS, LLC | 291,239 | $35,016,000 | 0.91% |